Copyright© 2010 TheraTorr Medical, Inc. All Rights Reserved.
Gary Paul Magnent - Chairman
Currently CEO of TheraTorr Medical, Inc, he is a Co-Founder and former CEO of Thrive Bioscience, Inc., Sage
Science, Inc., and Owl Scientific (now part of Thermo Fisher). Former VP of MJ Research (now Bio-Rad). Mr
Magnant has numerous patents and inventions and holds a number of bioscience related board positions.
Co-founder and former President of ActivBiotics (Lexington, MA) and ThermoCeramix (Montreal, Canada). Former
Chairman, Trustee, Hallowell Awardee, of Stoneridge, a private Montessori school in Beverly, MA (now
David W. Bertoni - Secretary, Treasurer
Dave Bertoni is a strategic marketing professional with extensive senior management experience in multi-national
corporate as well as startup environments. In the last 25-years he has brought over a dozen technical products to
domestic and international markets, as well as forming and funding three high-tech startups. Mr. Bertoni founded a
consulting firm, which assists medical technology and high tech firms to identify opportunities, establish clear
goals, overcome difficult business challenges and achieve sales and margin targets, continuous innovation, and
operational excellence. Before founding MarketSpace, Mr. Bertoni lead International Marketing and Product
Development for two product divisions at Salomon Group in France.
Timothy E. Moutafis, B.S. - Founder
Tim is a highly creative entrepreneur and engineer with more than 25 years of experience developing products in the
biomedical technology field. He founded HydroCision in 1994, which develops and markets surgical
instruments based on proprietary Fluidjet; technology. From 1991-94, he managed his own product
development consulting firm, serving many of the leading medical device companies in Massachusetts.
Mr. Moutafis was the Internal Entrepreneur at C.R. Bard, Inc., Senior Biomedical Engineer at Abiomed and a staff
engineer at Loeffler/MacConkey and Barry Wright Corporation. He has 35 US and International patents.
Irwin Heller, JD - Strategic Advisor
Irwin Heller is a Member at the prestigeous Boston law firm, Mintz Levin, where he served on the firm's Executive
Committee and was the firm's Managing Partner.
Mr. Heller devotes a significant portion of his practice to representing early-stage companies and individuals with
new products or concepts, both high tech and low tech, that require strategic partners or seed money. He also
provides wide-ranging assistance to growing companies of all sizes, including involvement in mergers and
acquisitions and public and private financings.
In addition, Irwin often is involved with joint ventures, product development, and marketing agreements designed to
advance the interests of multiple parties. For example, a significant portion of his career has involved project
financings, including leveraged lease transactions that require integrating and satisfying multiple parties. These
financings, totaling billions of dollars, financed waste and other alternative fuels to energy plants, among other
assets, on behalf of Fortune 500 companies and banks.
Don Freeman, Jr., Ph.D.
Dr. Freeman retired as the President/CEO of HydroCision, Inc. in 2002. He is currently on the board of directors of
Medical Record Bank, Electrolyzer Corporation, Respiratory Motion, and Pluromed.
Prior to HydroCision, he was Chairman/CEO of RadioMed Corporation, which was acquired by IBA. Previously, he
was President/CEO & Director at Intra-Sonix, a principal at Grayson Associates, a mid-market investment Bank,
CEO & Director at Xenotech Laboratories, Group Vice President at C.R. Bard, Inc., President of Davol (acquired by
C.R. Bard), and Corporate Director of New Business Development at Union Carbide after starting as a scientist with
the Linde Division of Union Carbide.
Dr. Freeman holds an ScB Degree from Brown and a PhD in chemistry from the University of Maryland, and did
post-doctoral research in physics at Duke. He completed the Advanced Management Program at Harvard Business
School. Don is a member at Boston Harbor Angels and is active in the MassMedic Ignite Program.
Dr. Ullrich Schwertschlag, MD, PhD, FACP - Medical Advisor
Dr. Schwertschlag is currently Chief Medical Officer of Attogen, Inc., and an Adjunct Associate Professor in
Pharmacology and Experimental Therapeutics at Tufts University, MA.
Dr. Schwertschlag has over twenty years of experience in senior clinical development roles in the
biopharmaceutical industry including large pharma and small biotech. He has extensive experience in translational
research, as well as preclinical and clinical development for drugs in major disease areas including oncology,
neurology, gastrointestinal diseases, immunology and inflammation. Additional competencies are in patient care,
preclinical laboratory investigation and FDA interactions/filings.
Dr. Schwertschlag completed his medical training (MD) at the University of Heidelberg and received his Ph.D. in
biophysics from the University of Freiburg, both Germany. He did his internship and residency at University
Heidelberg and Freiburg Hospitals in internal medicine and critical care. He accomplished postdoctoral training in
pharmacology at the University of Heidelberg and a clinical fellowship/housestaff training at the University of
Colorado Medical Center. He was an assistant professor and attending physician in internal medicine at Duke
University Medical Center, NC and the IUPUI hospitals and the VA medical center, IN.